Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.
Category: Science blog May 13, 2016
We’ve announced four new awards to speed up research in our Centres, particularly for cancers where survival is still poor.
Category: Science blog April 4, 2016
We take a look at five exciting projects that have just been funded by our Pioneer Award.
Category: Science blog March 14, 2016
A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a ‘targeted’ cancer drug.
Category: Science blog February 29, 2016
From immunotherapy to ‘targeted’ drugs, we report back from a recent conference on lung cancer.
Category: Science blog February 24, 2016
We take a look at our latest immunotherapy clinical trial, testing a new drug for people with head and neck cancers.
Category: Science blog February 4, 2016
To mark World Cancer Day, we take a look at how our discoveries over the decades are helping cancer patients all over the world right now.
Category: Science blog December 10, 2015
We explore the second of our Grand Challenges and ask the experts if we can wipe out cancers caused by the Epstein-Barr Virus.